Discontinuation report JETREA
| Report ID | 109082 |
| Drug Identification Number | 02452154 |
| Brand name | JETREA |
| Common or Proper name | Solution for Intravitreal Injection |
| Company Name | THROMBOGENICS NV |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | OCRIPLASMIN |
| Strength(s) | 1.25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVITREAL |
| Packaging size | 0.3mL |
| ATC code | S01XA |
| ATC description | OTHER OPHTHALMOLOGICALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-03-10 |
| Remaining supply date | 2020-03-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GASTON GEENSLAAN 1 LEUVEN, FLEMISH BRABANT BELGIUM 3001 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-03-20 | French | Compare |
| v3 | 2020-03-20 | English | Compare |
| v2 | 2020-03-20 | English | Compare |
| v1 | 2020-03-20 | English | Compare |
Showing 1 to 4 of 4